Accuray reported $448.01M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.04B 29.85M Sep/2026
AtriCure USD 717.54M 40.89M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 855.76M 17.26M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Trinity Biotech USD 101.92M 3.25M Mar/2026